The drug maker’s latest move toward shifting its legal tax headquarters abroad has drawn scorn from politicians, but it’s a shareholder-friendly tactic.
via NYT > Your Money http://ift.tt/1loAvYc
via WordPress http://ift.tt/1LfGVxD
The drug maker’s latest move toward shifting its legal tax headquarters abroad has drawn scorn from politicians, but it’s a shareholder-friendly tactic.
via NYT > Your Money http://ift.tt/1loAvYc
No comments:
Post a Comment